These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10650810

  • 1. Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.
    Castiglione F, Sarotto I, Fontana V, Destefanis M, Venturino A, Ferro S, Cardaropoli S, Orengo MA, Porcile G.
    Anticancer Res; 1999; 19(5C):4555-63. PubMed ID: 10650810
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer.
    Neri A, Marrelli D, Roviello F, DeMarco G, Mariani F, DeStefano A, Megha T, Caruso S, Corso G, Cioppa T, Pinto E.
    Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314
    [Abstract] [Full Text] [Related]

  • 4. bcl-2 and apoptosis in lymph node positive breast carcinoma.
    Berardo MD, Elledge RM, de Moor C, Clark GM, Osborne CK, Allred DC.
    Cancer; 1998 Apr 01; 82(7):1296-302. PubMed ID: 9529021
    [Abstract] [Full Text] [Related]

  • 5. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.
    Oncol Rep; 2007 Jul 01; 18(1):121-6. PubMed ID: 17549356
    [Abstract] [Full Text] [Related]

  • 6. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H, Era S.
    BMC Cancer; 2006 Jul 13; 6():187. PubMed ID: 16839413
    [Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 Jul 13; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 9. p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer.
    Kato T, Kameoka S, Kimura T, Tanaka S, Nishikawa T, Kobayashi M.
    Anticancer Res; 2002 Apr 12; 22(2B):1105-12. PubMed ID: 12168908
    [Abstract] [Full Text] [Related]

  • 10. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
    Zhang GJ, Kimijima I, Abe R, Watanabe T, Kanno M, Hara K, Tsuchiya A.
    Anticancer Res; 1998 Apr 12; 18(3B):1989-98. PubMed ID: 9677455
    [Abstract] [Full Text] [Related]

  • 11. Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.
    Kyndi M, Sørensen FB, Knudsen H, Alsner J, Overgaard M, Nielsen HM, Overgaard J.
    Acta Oncol; 2008 Apr 12; 47(4):608-17. PubMed ID: 18465329
    [Abstract] [Full Text] [Related]

  • 12. COX2 overexpression is a prognostic marker for Stage III breast cancer.
    Kim HS, Moon HG, Han W, Yom CK, Kim WH, Kim JH, Noh DY.
    Breast Cancer Res Treat; 2012 Feb 12; 132(1):51-9. PubMed ID: 21533532
    [Abstract] [Full Text] [Related]

  • 13. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH, Xu BH, Zhang P, Li Q, Zhao LM, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 2007 Feb 12; 29(2):137-40. PubMed ID: 17645853
    [Abstract] [Full Text] [Related]

  • 14. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.
    Yamashita H, Nishio M, Toyama T, Sugiura H, Zhang Z, Kobayashi S, Iwase H.
    Breast Cancer Res; 2004 Feb 12; 6(1):R24-30. PubMed ID: 14680497
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
    Kröger N, Milde-Langosch K, Riethdorf S, Schmoor C, Schumacher M, Zander AR, Löning T.
    Clin Cancer Res; 2006 Jan 01; 12(1):159-68. PubMed ID: 16397038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.